Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pretarsal versus preseptal botulinum toxin injection techniques for hemifacial spasm and blepharospasm
TCTR20180920006Completed
- Sponsor
- No
- Start
- May 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of botulinum toxin type A in hemifacial spasm (HFS) and idiopathic blepharospasm (BEB) (2 arms), sponsored by No. Primary endpoints: Efficacy, Complications and 2 more. Started May 2015; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
hemifacial spasm (HFS)idiopathic blepharospasm (BEB)
Beyond the preview
Go deeper on TCTR20180920006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180920006.